We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

CMS, China

Follow

New Updates on Foreigner’s Work Permit Renewal Policies

China - January 9 2018 China adopted a new foreigner's work permit application system since last April. Under the new system, a foreigner working in China can obtain a

CFDA issues regulation for online medical devices distribution, 20 December

China - January 8 2018 CFDA issued the Measures for the Administration and Supervision of Online Sales of Medical Devices ("Measures") on 20 December 2017. They will take

CFDA seeks comments for compassionate use of drugs in clinical trials, 15 December

China - January 8 2018 CFDA published the draft Administrative Measures for Drugs Compassionately used in Extended Clinical Trials (Draft for Comment) ("Draft") on 15

New Updates on China Social Insurance Policies

China - April 26 2016 Chinese employers are reported to bear one of the highest percentages of social insurance obligations in the world. According to statistics, in most

CFDA and NHFPC seek comments on the regulation of pharmaceutical representatives, 19 December

China - January 8 2018 CFDA and the National Health and Family Planning Commission ("NHFPC") announced the Administrative Measures for the Registration and Record-filing of

New Regulations on Judicial Review of Arbitration in China

China - January 15 2018 On 26 December 2017, the Chinese Supreme People's Court (the "SPC") published the Provisions on Issues relating to the Reporting and Review of Cases

New Updates on Foreigner’s Work Permit Renewal Policies

China - January 9 2018 China adopted a new foreigner's work permit application system since last April. Under the new system, a foreigner working in China can obtain a

CFDA seeks comments for compassionate use of drugs in clinical trials, 15 December

China - January 8 2018 CFDA published the draft Administrative Measures for Drugs Compassionately used in Extended Clinical Trials (Draft for Comment) ("Draft") on 15

CFDA clarifies the prioritised evaluation regime, 28 December

China - January 8 2018 China Food and Drug Administration ("CFDA") issued the Opinions on Encouraging the Prioritised Evaluation and Approval for Drug Innovations

CFDA and NHFPC seek comments on the regulation of pharmaceutical representatives, 19 December

China - January 8 2018 CFDA and the National Health and Family Planning Commission ("NHFPC") announced the Administrative Measures for the Registration and Record-filing of